Prognostic Factors and Survival Outcomes by Disease Subtypes in a Cohort of Iranian Patients with acute leukemia

Sahar Ravanshad; Zahra Fahimian; Parsa Shoghi; Ali Moradi; Valareza Alizadeh; Negar Javdan; Hassan Mehrad-Majd

Volume 10, Issue 2 , June 2023, , Pages 38-42

  Introduction: Studying the survival factors of leukemia patients can lead to a reduction in healthcare costs. This study aimed to evaluate the survival rate and potential predictive factors in leukemia patients in northeast Iran.Methods: Baseline demographic and clinical data of patients referred to ...  Read More

The Mediterranean diet and lung cancer; a review on case-control studies

Sepideh Hejazi; Sahar Ravanshad; Samaneh Sajjadi

Volume 8, Issue 1 , March 2021, , Pages 31-34

  Lung cancer is among the most common types of cancer with considerable mortality and morbidity around the globe. There are various risk factors involved in the development of lung cancer, and cancer prevention plans are mainly based on controlling the modifiable risk factors. While tobacco smoking is ...  Read More

Fake Traditional Healers with Superstitious Magical Treatments and Their Practices Regarding Children's Diseases

Yalda Ravanshad; Mohadese Golsorkhi; Sahar Ravanshad; Zahra sadat Mohajeri; Anoush Azarfar

Volume 7, Issue 1 , March 2020, , Pages 1-4

  Introduction: Nowadays, fake doctors, known as “Bandis” in our country Iran, represent themselves as traditional healers and use superstitious ideas for the healing of the ill, especially children. Their activities do not comply with any scientific methods. No research has been focused on ...  Read More

Comparative Evaluation of Tacrolimus and Cyclosporine in Patients with Steroid-resistant Nephrotic Syndrome: A Systematic Review and Meta-analysis

Yalda Ravanshad; Abbasali Zeraati; Mohadese Golsorkhi; Sahar Ravanshad; Anoush Azarfar; Hanieh Jafari

Volume 6, Issue 3 , September 2019, , Pages 123-134

  Introduction: To date, several randomized trials have compared calcineurin inhibitors, especially tacrolimus, with cyclosporine in patients with steroid-resistant nephrotic syndrome, proposing conflicting results. Use of immunosuppressive therapy for the treatment of resistant nephrotic syndrome ...  Read More